英搏爾(300681.SZ):擬將珠海鼎元100%股權轉讓給芯創精密
格隆匯7月2日丨英搏爾(300681.SZ)公佈,爲優化公司資產結構,提高資產運營效率,促進公司高質量發展,珠海英搏爾電氣股份有限公司(以下簡稱“公司”或“轉讓方”)將持有的珠海鼎元新能源汽車電氣研究院有限公司(以下簡稱“珠海鼎元”或“目標公司”)100%股權轉讓給珠海芯創精密製造有限公司(以下簡稱“芯創精密”或“受讓方”)。本次交易作價人民幣2.389億元。本次股權轉讓完成後,公司不再持有珠海鼎元股權,珠海鼎元不再納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.